The price of a cigarette: 20 minutes of life?

IF 5.3 1区 医学 Q1 PSYCHIATRY Addiction Pub Date : 2024-12-29 DOI:10.1111/add.16757
Sarah E. Jackson, Martin J. Jarvis, Robert West
{"title":"The price of a cigarette: 20 minutes of life?","authors":"Sarah E. Jackson,&nbsp;Martin J. Jarvis,&nbsp;Robert West","doi":"10.1111/add.16757","DOIUrl":null,"url":null,"abstract":"<p>Tobacco smoking is one of the largest preventable causes of disease, disability, and premature death globally [<span>1</span>]. Epidemiological studies report the harms associated with smoking using a range of metrics, including absolute risks, odds ratios, risk ratios, hazard ratios, population attributable fractions, and quality-adjusted life years. Conveying these harms in a clear and accessible way that resonates with smokers can be challenging. One potentially impactful way to express the harm caused by smoking is to estimate the average loss of life expectancy for each cigarette smoked.</p><p>In 2000, the BMJ published an estimate suggesting that each cigarette smoked in Britain shortens a smoker's life by an average of 11 minutes [<span>2</span>]. As the authors acknowledged, their estimate made some important assumptions, for which we now have better and more up-to-date data. Their mortality estimate relied solely on epidemiological data from British male doctors followed up for 40 years to 1991 [<span>3</span>]. Their estimate of lifetime cigarette consumption was based on a figure for men of 15.8 per day from age 17 to 71 years, as assessed in 1996 [<span>4</span>].</p><p>Data are now available on male mortality outcomes from the British Doctors Study at 50-year follow-up to 2001 [<span>5</span>] and on female mortality outcomes from the Million Women Study, also carried out in Britain, to 2011 [<span>6</span>]. These studies found that after adjusting for important confounders (e.g., socioeconomic position), smokers who did not stop lost approximately 10 (men) to 11 (women) years of life expectancy [<span>5, 6</span>] compared with the earlier estimate of 6.5 years [<span>2</span>]. Women in 1996 smoked an average of 13.6 cigarettes per day [<span>4</span>]. Therefore, other things being equal, this would lead to an increase in the estimated loss of life expectancy per cigarette to 20 minutes overall: 17 minutes for men (11*10/6.5) and 22 minutes for women ((11*11/6.5)*(15.8/13.6); see supplementary file for a more detailed explanation of the calculation).</p><p>Since the original estimate was published in the BMJ, average daily cigarette consumption has reduced from 15.8 to 11.5 per day for men and from 13.6 to 9.5 per day for women [<span>7</span>]. If the reduction in daily cigarette consumption had been matched by a reduction in toxicant intake, the loss of life expectancy per cigarette would remain unchanged. However, it is possible that smokers nowadays smoke each cigarette more intensively than they did in 1996 to compensate for smoking fewer cigarettes [<span>8-10</span>]. If so, then the loss of life expectancy per cigarette might be greater than it was 25 years ago. The best available measure we have of toxicant exposure over the period of interest is the concentration of the nicotine metabolite, cotinine, in the saliva of smokers [<span>11</span>]. Nicotine itself is not particularly harmful, but it can serve as a surrogate marker for exposure to tar and other harmful compounds [<span>11, 12</span>]. The Health Survey for England has gathered cotinine data from representative samples of adult smokers almost every other year from 1993 to 2019 [<span>13</span>]. These data show only a modest change in cotinine concentration per cigarette as cigarette consumption has declined [<span>14</span>]. Therefore, it seems reasonable to assume that there has not been a substantial increase in toxicant exposure per cigarette, so the figures of 17 minutes loss of life expectancy per cigarette for men and 22 minutes for women remain the best estimates.</p><p>Epidemiological data indicate that the harm caused by smoking is cumulative and the sooner the person stops, and the more cigarettes they avoid smoking, the longer they live [<span>5, 6</span>]. Thus, a person smoking 10 cigarettes per day who quits smoking on the 1st of January 2025 could prevent loss of a full day of life by the 8th of January, a week of life by the 20th of February, and a month by the 5th of August. By the end of the year, they could have avoided losing 50 days of life.</p><p>Studies suggest that smokers typically lose about the same number of healthy years as they do total years of life [<span>15</span>]. Thus smoking primarily eats into the relatively healthy middle years rather than shortening the period at the end of life, which is often marked by chronic illness or disability. So a 60-year-old smoker will typically have the health profile of a 70-year-old non-smoker [<span>5, 6</span>].</p><p>As with the BMJ 2000 estimate, our updated figure comes with some important caveats. First of all, these are averages across the population and across ages. Some smokers live long and healthy lives while others succumb to smoking-related diseases and even death in their 40s [<span>16</span>]. This variation will be due to differences in smoking patterns (the number of puffs, depth of inhalation, etc.), the type of cigarette smoked, and individual susceptibility to the toxicants in cigarette smoke. In addition, the harm caused will not be the same for every cigarette smoked across the life span. The health risks of smoking are not linear [<span>17</span>] and it is not enough just to reduce consumption – total cessation is required to achieve the maximum benefits for health and life [<span>1</span>]. Within individuals, any potential benefits from reduced consumption may be completely offset by increased puffing and inhalation of the remaining cigarettes. Age of initiation may also play a role, with people starting to smoke at a younger age being potentially more vulnerable to smoking-related diseases [<span>18</span>]. Evidence from the mortality studies shows the benefits of stopping smoking for life expectancy are greater the sooner a person quits [<span>5, 6</span>]. Another caveat is that we assumed the number of cigarettes per day was constant over the lifetime. In addition, tar-to-nicotine ratios have declined over the decades [<span>19</span>] and given that most of the harm from smoking comes from the tar, it is possible that exposure to toxicants per cigarette may have reduced. If so, then our estimates of loss of life years per cigarette would be somewhat high, but the true figure would still most likely be considerably higher than the BMJ 2000 estimate.</p><p>In conclusion, we estimate that on average, smokers in Britain who do not quit lose approximately 20 minutes of life expectancy for each cigarette they smoke. This is time that would likely be spent in relatively good health. Stopping smoking at every age is beneficial but the sooner smokers get off this escalator of death the longer and healthier they can expect their lives to be.</p><p><b>Sarah E. Jackson:</b> Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); visualization (equal); writing—original draft (equal). <b>Martin J. Jarvis:</b> Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); visualization (equal). <b>Robert West:</b> Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing—original draft (equal).</p><p>SEJ received payment from Freuds+ communications agency for undertaking this work. MJJ declares no competing interests. RW undertakes paid training for Everyone Health, a company that supports smokers with quitting, and is a paid advisor to the Freuds+ communications agency that runs antismoking campaigns for the English Office for Health Improvement and Disparities. He is a paid advisor to QNovia, a company that is developing a therapeutic inhaled nicotine delivery device. He is an unpaid director of the Unlocking Behaviour Change Community Interest Company and an unpaid advisor to company producing the Smoke Free mobile application. All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 5","pages":"810-812"},"PeriodicalIF":5.3000,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16757","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/add.16757","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Tobacco smoking is one of the largest preventable causes of disease, disability, and premature death globally [1]. Epidemiological studies report the harms associated with smoking using a range of metrics, including absolute risks, odds ratios, risk ratios, hazard ratios, population attributable fractions, and quality-adjusted life years. Conveying these harms in a clear and accessible way that resonates with smokers can be challenging. One potentially impactful way to express the harm caused by smoking is to estimate the average loss of life expectancy for each cigarette smoked.

In 2000, the BMJ published an estimate suggesting that each cigarette smoked in Britain shortens a smoker's life by an average of 11 minutes [2]. As the authors acknowledged, their estimate made some important assumptions, for which we now have better and more up-to-date data. Their mortality estimate relied solely on epidemiological data from British male doctors followed up for 40 years to 1991 [3]. Their estimate of lifetime cigarette consumption was based on a figure for men of 15.8 per day from age 17 to 71 years, as assessed in 1996 [4].

Data are now available on male mortality outcomes from the British Doctors Study at 50-year follow-up to 2001 [5] and on female mortality outcomes from the Million Women Study, also carried out in Britain, to 2011 [6]. These studies found that after adjusting for important confounders (e.g., socioeconomic position), smokers who did not stop lost approximately 10 (men) to 11 (women) years of life expectancy [5, 6] compared with the earlier estimate of 6.5 years [2]. Women in 1996 smoked an average of 13.6 cigarettes per day [4]. Therefore, other things being equal, this would lead to an increase in the estimated loss of life expectancy per cigarette to 20 minutes overall: 17 minutes for men (11*10/6.5) and 22 minutes for women ((11*11/6.5)*(15.8/13.6); see supplementary file for a more detailed explanation of the calculation).

Since the original estimate was published in the BMJ, average daily cigarette consumption has reduced from 15.8 to 11.5 per day for men and from 13.6 to 9.5 per day for women [7]. If the reduction in daily cigarette consumption had been matched by a reduction in toxicant intake, the loss of life expectancy per cigarette would remain unchanged. However, it is possible that smokers nowadays smoke each cigarette more intensively than they did in 1996 to compensate for smoking fewer cigarettes [8-10]. If so, then the loss of life expectancy per cigarette might be greater than it was 25 years ago. The best available measure we have of toxicant exposure over the period of interest is the concentration of the nicotine metabolite, cotinine, in the saliva of smokers [11]. Nicotine itself is not particularly harmful, but it can serve as a surrogate marker for exposure to tar and other harmful compounds [11, 12]. The Health Survey for England has gathered cotinine data from representative samples of adult smokers almost every other year from 1993 to 2019 [13]. These data show only a modest change in cotinine concentration per cigarette as cigarette consumption has declined [14]. Therefore, it seems reasonable to assume that there has not been a substantial increase in toxicant exposure per cigarette, so the figures of 17 minutes loss of life expectancy per cigarette for men and 22 minutes for women remain the best estimates.

Epidemiological data indicate that the harm caused by smoking is cumulative and the sooner the person stops, and the more cigarettes they avoid smoking, the longer they live [5, 6]. Thus, a person smoking 10 cigarettes per day who quits smoking on the 1st of January 2025 could prevent loss of a full day of life by the 8th of January, a week of life by the 20th of February, and a month by the 5th of August. By the end of the year, they could have avoided losing 50 days of life.

Studies suggest that smokers typically lose about the same number of healthy years as they do total years of life [15]. Thus smoking primarily eats into the relatively healthy middle years rather than shortening the period at the end of life, which is often marked by chronic illness or disability. So a 60-year-old smoker will typically have the health profile of a 70-year-old non-smoker [5, 6].

As with the BMJ 2000 estimate, our updated figure comes with some important caveats. First of all, these are averages across the population and across ages. Some smokers live long and healthy lives while others succumb to smoking-related diseases and even death in their 40s [16]. This variation will be due to differences in smoking patterns (the number of puffs, depth of inhalation, etc.), the type of cigarette smoked, and individual susceptibility to the toxicants in cigarette smoke. In addition, the harm caused will not be the same for every cigarette smoked across the life span. The health risks of smoking are not linear [17] and it is not enough just to reduce consumption – total cessation is required to achieve the maximum benefits for health and life [1]. Within individuals, any potential benefits from reduced consumption may be completely offset by increased puffing and inhalation of the remaining cigarettes. Age of initiation may also play a role, with people starting to smoke at a younger age being potentially more vulnerable to smoking-related diseases [18]. Evidence from the mortality studies shows the benefits of stopping smoking for life expectancy are greater the sooner a person quits [5, 6]. Another caveat is that we assumed the number of cigarettes per day was constant over the lifetime. In addition, tar-to-nicotine ratios have declined over the decades [19] and given that most of the harm from smoking comes from the tar, it is possible that exposure to toxicants per cigarette may have reduced. If so, then our estimates of loss of life years per cigarette would be somewhat high, but the true figure would still most likely be considerably higher than the BMJ 2000 estimate.

In conclusion, we estimate that on average, smokers in Britain who do not quit lose approximately 20 minutes of life expectancy for each cigarette they smoke. This is time that would likely be spent in relatively good health. Stopping smoking at every age is beneficial but the sooner smokers get off this escalator of death the longer and healthier they can expect their lives to be.

Sarah E. Jackson: Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); visualization (equal); writing—original draft (equal). Martin J. Jarvis: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); visualization (equal). Robert West: Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); writing—original draft (equal).

SEJ received payment from Freuds+ communications agency for undertaking this work. MJJ declares no competing interests. RW undertakes paid training for Everyone Health, a company that supports smokers with quitting, and is a paid advisor to the Freuds+ communications agency that runs antismoking campaigns for the English Office for Health Improvement and Disparities. He is a paid advisor to QNovia, a company that is developing a therapeutic inhaled nicotine delivery device. He is an unpaid director of the Unlocking Behaviour Change Community Interest Company and an unpaid advisor to company producing the Smoke Free mobile application. All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一根烟的价格:20分钟的生命?
吸烟对健康的危害不是线性的,仅仅减少吸烟是不够的,要达到对健康和生命的最大益处,需要完全戒烟。对于个人而言,减少吸烟带来的任何潜在好处都可能被增加吸烟和吸入剩余香烟所完全抵消。开始吸烟的年龄也可能起作用,人们在较年轻的时候开始吸烟,可能更容易患与吸烟有关的疾病。来自死亡率研究的证据表明,戒烟对预期寿命的好处越大,戒烟越早[5,6]。另一个警告是,我们假设每天吸烟的数量在一生中是恒定的。此外,在过去的几十年里,焦油与尼古丁的比例有所下降,考虑到吸烟的大部分危害来自焦油,每根香烟接触到的有毒物质可能减少了。如果是这样的话,那么我们对每根香烟损失的寿命年数的估计会有些高,但真实的数字很可能仍然比英国医学杂志2000年的估计要高得多。总之,我们估计,在英国,不戒烟的吸烟者平均每吸一支烟就会减少大约20分钟的预期寿命。这段时间很可能是在相对健康的情况下度过的。在任何年龄停止吸烟都是有益的,但吸烟者越早从死亡扶梯上下来,他们的寿命就越长,越健康。Sarah E. Jackson:概念化(平等);数据管理(相等);形式分析(相等);调查(平等);方法(平等);可视化(平等);写作-原稿(同等)。Martin J. Jarvis:数据管理(equal);形式分析(相等);调查(平等);方法(平等);可视化(平等)。罗伯特·韦斯特:概念化(平等);数据管理(相等);形式分析(相等);调查(平等);方法(平等);写作-原稿(同等)。SEJ从弗洛伊德+通信代理公司收到了承担这项工作的报酬。MJJ声明没有竞争利益。RW为支持吸烟者戒烟的“人人健康”公司提供有偿培训,并为为英国健康改善和差距办公室开展反吸烟运动的“弗洛伊德+”传播机构担任有偿顾问。他是QNovia公司的有偿顾问,该公司正在开发一种治疗性吸入尼古丁输送装置。他是解锁行为改变社区利益公司的无薪董事,也是生产无烟移动应用程序的公司的无薪顾问。所有作者声明与烟草公司、电子烟制造商或其代表没有财务联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Addiction
Addiction 医学-精神病学
CiteScore
10.80
自引率
6.70%
发文量
319
审稿时长
3 months
期刊介绍: Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.
期刊最新文献
Decline of phosphatidylethanol (B-PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B-PEth with self-reported alcohol intake. Glucagon-like peptide-1 receptor agonists in alcohol use disorder: Multi-system effects, early clinical promise and uncertain long-term use. On the need and contents of a specific addiction recovery research agenda. Availability of nitazenes via cryptomarkets and surface web shops: An observational study. Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web-scraped and government-maintained registries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1